Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®)

References

• Li MK, Crawford JM. The pathology of cholestasis. Semin Liver Dis 2004; 24: 21–42
   PubMed Web of Science ®Google Scholar
• Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003; 17: 857–70
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000; 95: 497–502
   PubMed Web of Science ®Google Scholar
• Schirrmacher S, Blumenstein I, Stein J. Pathogenesis and treatment of pruritus in patients with cholestasis. Z Gastroenterol 2003; 41: 259–62
   PubMedGoogle Scholar
• Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100: 468–75
   PubMed Web of Science ®Google Scholar
• Stange J, Mitzner SR, Ramlow W, Gliesche T, Hickstein H, Schmidt R. A new procedure for the removal of protein-bound drugs and toxins. ASAIO J 1993; 39: M621–5
   PubMedGoogle Scholar
• Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002; 26: 103–10
   PubMed Web of Science ®Google Scholar
• Sturm E, Franssen CF, Gouw A, Staels B, Boverhof R, De Knegt RJ, et al. Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A-I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC). Liver 2002; 22(Suppl): 72–5
   Google Scholar
• Doria C, Mandala L, Smith J, Vitale CH, Lauro A, Gruttadauria S, et al. Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritus. Liver Transpl 2003; 9: 437–43
   PubMedGoogle Scholar
• Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10: 107–14
   PubMed Web of Science ®Google Scholar
• Bellmann R, Feistritzer C, Zoller H, Graziadei IW, Schwaighofer H, Propst A, et al. Treatment of intractable pruritus in drug-induced cholestasis with albumin dialysis: a report of two cases. ASAIO J 2004; 50: 387–91
   PubMedGoogle Scholar
• Pares A, Cisneros L, Salmeron JM, Caballeria L, Mas A, Torras A, et al. Extracorporeal albumin dialysis: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis. Am J Gastroenterol 2004; 99: 1105–10
   PubMed Web of Science ®Google Scholar
• Stauber RE, Krisper P, Zollner G, Iberer F, Beuers U, Trauner M. Extracorporeal albumin dialysis in a patient with primary sclerosing cholangitis: effect on pruritus and bile acid profile. Int J Artif Organs 2004; 27: 342–4
   PubMedGoogle Scholar
• Acevedo Ribo M, Moreno Planas JM, Sanz Moreno C, Rubio Gonzalez EE, Rubio Gonzalez E, Boullosa Grana E, et al. Therapy of intractable pruritus with MARS. Transplant Proc 2005; 37: 1480–1
   PubMed Web of Science ®Google Scholar
• Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus: a new extracorporeal system for the treatment of liver failure. J Hepatol 2003; 39: 984–90
   PubMed Web of Science ®Google Scholar
• Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 1999; 23: 81–6
   PubMed Web of Science ®Google Scholar
• Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 2003; 289: 217–22
   PubMed Web of Science ®Google Scholar
• Rifai K, Ernst T, Kretschmer U, Hafer C, Haller H, Manns MP, et al. One for two: the Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005; 23: 298–302
   PubMed Web of Science ®Google Scholar
• Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol 2005; 43: 451–7
   PubMed Web of Science ®Google Scholar
• Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, et al. Detoxifying capacity and kinetics of prometheus: a new extracorporeal system for the treatment of liver failure. Blood Purif 2005; 23: 349–58
   PubMed Web of Science ®Google Scholar